AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
285 hedge funds and large institutions have $2.72B invested in Amedisys in 2024 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 92 increasing their positions, 105 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
1.19% less ownership
Funds ownership: 91.83% → 90.64% (-1.2%)
12% less repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 105
82% less call options, than puts
Call options by funds: $17.1M | Put options by funds: $94.3M
Holders
285
Holding in Top 10
13
Calls
$17.1M
Puts
$94.3M
Top Buyers
| 1 | +$95.8M | |
| 2 | +$19.2M | |
| 3 | +$18.3M | |
| 4 |
SGCM
Sand Grove Capital Management
London,
United Kingdom
|
+$17.3M |
| 5 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$14M |
Top Sellers
| 1 | -$31.9M | |
| 2 | -$29.3M | |
| 3 | -$19.3M | |
| 4 |
MAM
Melqart Asset Management
London,
United Kingdom
|
-$18.7M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
-$18.3M |